NT5E and neoplasm: CD73 is a novel immune checkpoint associated with adenosine metabolism that promotes tumor progression and angiogenesis by suppressing the antitumor immune response through silencing tumor-infiltrating T- and NK-cell activation while amplifying regulatory T-cell activation.